Biology Reference
In-Depth Information
antibodies with the CD4 binding site of human immunodeficiency
virus type 1 gp120.
J Virol
77
: 642-658.
172. Pantophlet R, Wilson IA, Burton DR. (2003) Hyperglycosylated
mutants of human immunodeficiency virus (HIV) type 1 monomeric
gp120 as novel antigens for HIV vaccine design.
J Virol
77
: 5889-5901.
173. Stamatatos L, Wiskerchen M, Cheng-Mayer C. (1998) Effect of major
deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1
isolate on viral envelope structure, cell entry, and replication.
AIDS Res
Hum Retroviruses
14
: 1129-1139.
174. Stamatatos L, Lim M, Cheng-Mayer C. (2000) Generation and struc-
tural analysis of soluble oligomeric gp140 envelope proteins derived
from neutralization-resistant and neutralization-susceptible primary
HIV type 1 isolates [In Process Citation].
AIDS Res Hum Retroviruses
16
: 981-994.
175. Zwick MB, Komori HK, Stanfield RL,
et al
. (2004) The long third
complementarity-determining region of the heavy chain is important in
the activity of the broadly neutralizing anti-human immunodeficiency
virus type 1 antibody 2F5.
J Virol
78
: 3155-3161.
176. LaCasse RA, Follis KE, Trahey M,
et al
. (1999) Fusion-competent vac-
cines: broad neutralization of primary isolates of HIV.
Science
283
:
357-362.
177. Wild C, Oas T, McDanal C,
et al
. (1992) A synthetic peptide inhibitor
of human immunodeficiency virus replication: correlation between
solution structure and viral inhibition.
Proc Natl Acad Sci USA
89
:
10537-10541.
178. Zanetti G, Briggs JA, Grunewald K,
et al
. (2006) Cryo-electron tomo-
graphic structure of an immunodeficiency virus envelope complex in
situ.
PLoS Pathog
2
: e83.
179. Zhu P, Liu J, Bess J, Jr.,
et al
. (2006) Distribution and three-dimen-
sional structure of AIDS virus envelope spikes.
Nature
441
: 847-852.
180. Mascola JR, Montefiori DC. (2003) HIV-1: nature's master of dis-
guise.
Nat Med
9
: 393-394.
181. Cole KS, Alvarez M, Elliott DH,
et al
. (2001) Characterization of neu-
tralization epitopes of simian immunodeficiency virus (SIV) recognized
by rhesus monoclonal antibodies derived from monkeys infected with
an attenuated SIV strain.
Virology
290
: 59-73.
182. Sattentau QJ, Moore JP. (1991) Conformational changes induced in
the human immunodeficiency virus envelope glycoprotein by soluble
CD4 binding.
J Exp Med
174
: 407-415.
